RetinalGenix Technologies (RTGN) Preferred Shares (2020 - 2021)
RetinalGenix Technologies' (RTGN) quarterly Preferred Shares came in at $300.0 in Q3 2021, little changed quarter-over-quarter from $300.0 in Q4 2020.
RetinalGenix Technologies (RTGN) Preferred Shares (2020 - 2021) Analysis & Trends
RetinalGenix Technologies has disclosed Preferred Shares across 2 years of filings, most recently posting $300.0 for Q3 2021.
- Preferred Shares for Q3 2021 came in at $300.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2021 was $300.0 (changed N/A YoY), and the FY2020 annual result was $300.0, changed N/A from the prior year.
- Preferred Shares came in at $300.0 for Q3 2021 at RetinalGenix Technologies, roughly flat from $300.0 in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $300.0 in Q4 2020 to a low of $300.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | - |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | RetinalGenix Technologies | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 300.00 |
| Dec 31, 2020 | 300.00 |